Search results
3 Biotech Stocks to Buy and Hold Through 2030 and Beyond
Motley Fool via Yahoo Finance· 9 hours agoWith a pipeline that carries several dozen programs, the company should deliver plenty of regulatory...
Moderna Breaks Out For The First Time In A Year After Covid Shot Wallops Sales Views
Investor's Business Daily· 20 minutes agoOn the stock market today, Moderna stock surged 12.7% to 125.59. Shares topped a buy point at 115.89...
Shhh! 3 Secret Biotech Stocks Flying Below Wall Street's Radar
InvestorPlace· 1 day agoBiotech stocks are full of intriguing innovators who could help pave the way for greater gains over...
Biotech Stock Roundup: GILD's GSK' Q1 Earnings, DCPH Soars on Acquisition News & More
Zacks via Yahoo Finance· 6 hours agoOver the past six months, shares of MRNA have risen 46.27%. (See the last biotech stock roundup...
Stock Market Crash Alert: 3 Must-Buy Biotech Stocks When Prices Plunge
InvestorPlace· 1 day agoWhile a weakening economy and a subsequent dip in the stock market are unfortunate, they are...
Stock Market Crash Warning: Don't Get Caught Holding These 3 Biotech Stocks
InvestorPlace· 2 days agoInvesting in the biotech sphere isn’t for the faint of heart, and you should steer clear of the ...
3 Biotech Stocks with Blockbuster Drug Pipelines: April Edition
InvestorPlace· 2 days agoBiotech stocks offer the opportunity to invest in life-saving treatments and drugs. If you want to...
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 4 hours agoModerna stock broke out for the first time in over a year on May 2 after the biotech company notched...
Trinity Biotech (NASDAQ:TRIB) Now Covered by Analysts at StockNews.com
ETF DAILY NEWS· 15 hours agoResearch analysts at StockNews.com started coverage on shares of Trinity Biotech (NASDAQ:TRIB – Get Free Report) in a report issued on Thursday. The brokerage set a “buy” ...
No. 1 Biotech Stock Pops After Biggest Moneymaker Tops Sales Views
Investor's Business Daily· 1 day agoThe company makes Ingrezza, a treatment for the movement disorder known as tardive dyskinesia.